137 related articles for article (PubMed ID: 10372729)
1. Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome.
Wahrenberg H; Ek I; Reynisdottir S; Carlström K; Bergqvist A; Arner P
J Clin Endocrinol Metab; 1999 Jun; 84(6):2182-7. PubMed ID: 10372729
[TBL] [Abstract][Full Text] [Related]
2. Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: a possible link to insulin resistance?
Ek I; Arner P; Bergqvist A; Carlström K; Wahrenberg H
J Clin Endocrinol Metab; 1997 Apr; 82(4):1147-53. PubMed ID: 9100587
[TBL] [Abstract][Full Text] [Related]
3. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
4. Regulation of lipolysis in fat cells of obese women during long-term hypocaloric diet.
Hellström L; Reynisdottir S; Langin D; Rössner S; Arner P
Int J Obes Relat Metab Disord; 1996 Aug; 20(8):745-52. PubMed ID: 8856398
[TBL] [Abstract][Full Text] [Related]
5. Catecholamine-induced adipocyte lipolysis in human hyperthyroidism.
Hellström L; Wahrenberg H; Reynisdottir S; Arner P
J Clin Endocrinol Metab; 1997 Jan; 82(1):159-66. PubMed ID: 8989252
[TBL] [Abstract][Full Text] [Related]
6. Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity--a metabolic predictor of weight loss in obese subjects.
Hellström L; Rössner S; Hagström-Toft E; Reynisdottir S
Int J Obes Relat Metab Disord; 1997 Apr; 21(4):314-20. PubMed ID: 9130030
[TBL] [Abstract][Full Text] [Related]
7. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
[TBL] [Abstract][Full Text] [Related]
8. Regional and gender variations in adipose tissue lipolysis in response to weight loss.
Mauriège P; Imbeault P; Langin D; Lacaille M; Alméras N; Tremblay A; Després JP
J Lipid Res; 1999 Sep; 40(9):1559-71. PubMed ID: 10484603
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome.
Adeniji AA; Essah PA; Nestler JE; Cheang KI
J Womens Health (Larchmt); 2016 Jun; 25(6):638-45. PubMed ID: 26871978
[TBL] [Abstract][Full Text] [Related]
10. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
[TBL] [Abstract][Full Text] [Related]
11. Body composition in lean women with polycystic ovary syndrome: effect of ethinyl estradiol and drospirenone combination.
Aydin K; Cinar N; Aksoy DY; Bozdag G; Yildiz BO
Contraception; 2013 Mar; 87(3):358-62. PubMed ID: 22898361
[TBL] [Abstract][Full Text] [Related]
12. Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.
Morin-Papunen L; Vauhkonen I; Koivunen R; Ruokonen A; Martikainen H; Tapanainen JS
J Clin Endocrinol Metab; 2003 Jan; 88(1):148-56. PubMed ID: 12519844
[TBL] [Abstract][Full Text] [Related]
13. The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women.
Nader S; Riad-Gabriel MG; Saad MF
J Clin Endocrinol Metab; 1997 Sep; 82(9):3074-7. PubMed ID: 9284746
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
Lemay A; Dewailly SD; Grenier R; Huard J
J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
[TBL] [Abstract][Full Text] [Related]
15. Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome.
Uras R; Orrù M; Pani F; Marotto MF; Pilloni M; Guerriero S; Etzi R; Zedda P; Sorge R; Lello S; Melis GB; Paoletti AM
Contraception; 2010 Aug; 82(2):131-8. PubMed ID: 20654753
[TBL] [Abstract][Full Text] [Related]
16. Regulation of lipolysis and lipoprotein lipase after weight loss in obese, postmenopausal women.
Berman DM; Nicklas BJ; Ryan AS; Rogus EM; Dennis KE; Goldberg AP
Obes Res; 2004 Jan; 12(1):32-9. PubMed ID: 14742840
[TBL] [Abstract][Full Text] [Related]
17. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects.
Van Harmelen V; Lönnqvist F; Thörne A; Wennlund A; Large V; Reynisdottir S; Arner P
Int J Obes Relat Metab Disord; 1997 Nov; 21(11):972-9. PubMed ID: 9368819
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
19. Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives.
Hellström L; Langin D; Reynisdottir S; Dauzats M; Arner P
Diabetologia; 1996 Aug; 39(8):921-8. PubMed ID: 8858214
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate.
Markantes G; Saltamavros AD; Vervita V; Armeni AK; Karela A; Adonakis G; Decavalas G; Georgopoulos NA
Gynecol Endocrinol; 2011 Dec; 27(12):971-7. PubMed ID: 21501001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
